Healthcare facilities company Artemis Medicare Services announced Q4FY23 & FY23 results: Q4FY23: Net revenue from operations increased by 31% to Rs 1,953 million from Rs 1,494 million EBITDA increased by 53% to Rs 280 million from Rs 183 million with a margin of 14.4% PBT increased by 71% to Rs 140 million from Rs 82 million with a margin of 7.2% Net debt of Rs 1,906 million as of 31 st March 2023; Net Debt/Equity of 0.47x FY23: Net revenue from operations stood at Rs 7,374 million showing an uptick of 33% EBITDA increased by 42% to Rs 1,013 million from Rs 714 million; EBITDA margin stood at 13.7% PAT increased by 21% to Rs 380 million from Rs 314 million with a PAT margin of 5.2% Commenting on the performance, Onkar S Kanwar, Chairman, Artemis Medicare Services, said, “Artemis ended FY23 on a high note with a consistent growth in performance throughout the year. We continue to achieve various milestones in clinical and non-clinical excellence and take pride in making quality healthcare available to our community. We have also invested in expanding our footprint through our brands including Artemis Lite, Daffodils, and Artemis Cardiac Care across the country. We continue to strive to become one of the most trusted brands in India keeping in mind the interest of patients, shareholders and employees of the company.” Announcing the results, Dr Devlina Chakravarty, Managing Director, Artemis Medicare Services, said, “We have had a great year where we have shown improvement in most financial and operational parameters. During the year, we have steadily ramped up occupancy in the 2nd Tower which was commissioned in FY22 and the construction of the 3rd Tower with ~200 beds is going on in full swing with 22 new OPDs in the ground floor of the 3rd Tower already inaugurated.” Result PDF